CRISPR target prediction remains blunt tool for clinical applications.
Nature biotechnology, 37(3): 204-205 PMID 30833770 DOI 10.1038/s41587-019-0057-7
Abstract
This article has no abstract in PubMed.
Your browser does not allow saving data (e.g. private mode): bookmarks will be lost when the tab closes.